Dmitry Balyasny’s Kronos Bio KRON Stock Holding History

Dmitry Balyasny’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,509	Closed	-$18.1K	–	2512
2023 Q2	$18.1K	Buy	+10,509	New	+$16.7K	﹤0.01%	2159

Other funds holding KRON

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dmitry Balyasny's KRON Position: Q3 2023 in Review

Dmitry Balyasny sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 10,509 shares — an estimated $18.1K sold.

Dmitry Balyasny first reported a position in KRON in Q2 2023 and held it in 1 quarter. The position peaked at $18.1K in Q2 2023. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

Dmitry Balyasny reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
Dmitry Balyasny sold 10,509 Kronos Bio shares in Q3 2023, an estimated $18.1K.
Dmitry Balyasny first reported a position in Kronos Bio in Q2 2023 and held it in 1 quarter.
Dmitry Balyasny's Kronos Bio position peaked at $18.1K in Q2 2023.
63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.